In the BioHarmony Drug Report Database
Clascoterone
Winlevi (clascoterone) is a small molecule pharmaceutical. Clascoterone was first approved as Winlevi on 2020-08-26. The pharmaceutical is active against androgen receptor. Winlevi’s patents are valid until 2030-07-25 (FDA).
Trade Name
|
Winlevi |
|---|---|
Common Name
|
clascoterone |
ChEMBL ID
|
CHEMBL3590187 |
Indication
|
|
Drug Class
|
Antiandrogens |
Image (chem structure or protein)